FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891991146> ?p ?o ?g. }

• W2891991146 endingPage "1722" @default.
• W2891991146 startingPage "1713" @default.
• W2891991146 abstract "The eighth edition of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) stage classification (TNM) for nasopharyngeal carcinoma (NPC) was launched. It remains unknown if incorporation of nonanatomic factors into the stage classification would better predict survival. We prospectively recruited 518 patients with nonmetastatic NPC treated with radical intensity-modulated radiation therapy ± chemotherapy based on the eighth edition TNM. Recursive partitioning analysis (RPA) incorporating pretreatment plasma Epstein–Barr virus (EBV) DNA derived new stage groups. Multivariable analyses to calculate adjusted hazard ratios (AHRs) derived another set of stage groups. Five-year progression-free survival (PFS), overall survival (OS) and cancer-specific survival (CSS) were: Stage I (PFS 100%, OS 90%, CSS 100%), II (PFS 88%, OS 84%, CSS 95%), III (PFS 84%, OS 84%, CSS 90%) and IVA (PFS 71%, OS 75%, CSS 80%) (p < 0.001, p = 0.066 and p = 0.002, respectively). RPA derived four new stages: RPA-I (T1–T4 N0–N2 & EBV DNA <500 copies per mL; PFS 94%, OS 89%, CSS 96%), RPA-II (T1–T4 N0–N2 & EBV DNA ≥500 copies per mL; PFS 80%, OS 83%, CSS 89%), RPA-III (T1–T2 N3; PFS 64%, OS 83%, CSS 83%) and RPA-IVA (T3–T4 N3; PFS 63%, OS 60% and CSS 68%) (all with p < 0.001). AHR using covariate adjustment also yielded a valid classification (I: T1–T2 N0–N2; II: T3–T4 N0–N2 or T1–T2 N3 and III: T3–T4 N3) (all with p < 0.001). However, RPA stages better predicted survival for PS and CSS after bootstrapping replications. Our RPA-based stage groups revealed better survival prediction compared to the eighth edition TNM and the AHR stage groups." @default.
• W2891991146 created "2018-09-27" @default.
• W2891991146 creator A5008092548 @default.
• W2891991146 creator A5015827883 @default.
• W2891991146 creator A5016090230 @default.
• W2891991146 creator A5024313900 @default.
• W2891991146 creator A5029680277 @default.
• W2891991146 creator A5035460082 @default.
• W2891991146 creator A5037725319 @default.
• W2891991146 creator A5039974969 @default.
• W2891991146 creator A5045976890 @default.
• W2891991146 creator A5051378644 @default.
• W2891991146 creator A5062298059 @default.
• W2891991146 creator A5068896428 @default.
• W2891991146 creator A5069477231 @default.
• W2891991146 creator A5070808098 @default.
• W2891991146 creator A5074140939 @default.
• W2891991146 creator A5078180869 @default.
• W2891991146 creator A5081263991 @default.
• W2891991146 creator A5083227748 @default.
• W2891991146 creator A5085330947 @default.
• W2891991146 date "2018-12-24" @default.
• W2891991146 modified "2023-10-16" @default.
• W2891991146 title "The addition of pretreatment plasma Epstein–Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification" @default.
• W2891991146 cites W1049819953 @default.
• W2891991146 cites W1968017437 @default.
• W2891991146 cites W1982720422 @default.
• W2891991146 cites W2024122691 @default.
• W2891991146 cites W2028758880 @default.
• W2891991146 cites W2052818678 @default.
• W2891991146 cites W2058024895 @default.
• W2891991146 cites W2098802000 @default.
• W2891991146 cites W2102310008 @default.
• W2891991146 cites W2115044837 @default.
• W2891991146 cites W2117286343 @default.
• W2891991146 cites W2119785778 @default.
• W2891991146 cites W2132871252 @default.
• W2891991146 cites W2138066012 @default.
• W2891991146 cites W2149067175 @default.
• W2891991146 cites W2150434794 @default.
• W2891991146 cites W2161043223 @default.
• W2891991146 cites W2167359560 @default.
• W2891991146 cites W2174306046 @default.
• W2891991146 cites W2266578659 @default.
• W2891991146 cites W2280894559 @default.
• W2891991146 cites W2486952998 @default.
• W2891991146 cites W2501667437 @default.
• W2891991146 cites W2528196296 @default.
• W2891991146 cites W2565390820 @default.
• W2891991146 cites W2596704275 @default.
• W2891991146 cites W2607424519 @default.
• W2891991146 cites W2724172796 @default.
• W2891991146 cites W2742681205 @default.
• W2891991146 cites W2788548495 @default.
• W2891991146 cites W2791186216 @default.
• W2891991146 cites W2803292563 @default.
• W2891991146 doi "https://doi.org/10.1002/ijc.31856" @default.
• W2891991146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30192385" @default.
• W2891991146 hasPublicationYear "2018" @default.
• W2891991146 type Work @default.
• W2891991146 sameAs 2891991146 @default.
• W2891991146 citedByCount "74" @default.
• W2891991146 countsByYear W28919911462019 @default.
• W2891991146 countsByYear W28919911462020 @default.
• W2891991146 countsByYear W28919911462021 @default.
• W2891991146 countsByYear W28919911462022 @default.
• W2891991146 countsByYear W28919911462023 @default.
• W2891991146 crossrefType "journal-article" @default.
• W2891991146 hasAuthorship W2891991146A5008092548 @default.
• W2891991146 hasAuthorship W2891991146A5015827883 @default.
• W2891991146 hasAuthorship W2891991146A5016090230 @default.
• W2891991146 hasAuthorship W2891991146A5024313900 @default.
• W2891991146 hasAuthorship W2891991146A5029680277 @default.
• W2891991146 hasAuthorship W2891991146A5035460082 @default.
• W2891991146 hasAuthorship W2891991146A5037725319 @default.
• W2891991146 hasAuthorship W2891991146A5039974969 @default.
• W2891991146 hasAuthorship W2891991146A5045976890 @default.
• W2891991146 hasAuthorship W2891991146A5051378644 @default.
• W2891991146 hasAuthorship W2891991146A5062298059 @default.
• W2891991146 hasAuthorship W2891991146A5068896428 @default.
• W2891991146 hasAuthorship W2891991146A5069477231 @default.
• W2891991146 hasAuthorship W2891991146A5070808098 @default.
• W2891991146 hasAuthorship W2891991146A5074140939 @default.
• W2891991146 hasAuthorship W2891991146A5078180869 @default.
• W2891991146 hasAuthorship W2891991146A5081263991 @default.
• W2891991146 hasAuthorship W2891991146A5083227748 @default.
• W2891991146 hasAuthorship W2891991146A5085330947 @default.
• W2891991146 hasBestOaLocation W28919911461 @default.
• W2891991146 hasConcept C121608353 @default.
• W2891991146 hasConcept C126322002 @default.
• W2891991146 hasConcept C143998085 @default.
• W2891991146 hasConcept C146357865 @default.
• W2891991146 hasConcept C151730666 @default.
• W2891991146 hasConcept C207103383 @default.
• W2891991146 hasConcept C2776694085 @default.
• W2891991146 hasConcept C2778997737 @default.
• W2891991146 hasConcept C2780739268 @default.
• W2891991146 hasConcept C44249647 @default.

• next